Product Information
VENLAFAXINE HCL ER 37.5 MG CAP is a generic product labeled by Advagen Pharma Ltd., priced at $0.0850 per EA under NDC 72888017990. Its NADAC has been published 102 times since Jul 17, 2024.
Strength
37.5 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888017990
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203332On Market Since
3/20/2020
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has been published 102 times since Jul 17, 2024, and over the history we have for it it has risen 16.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0850 per EA |
|---|---|
| All-time high | $0.0954 (Oct 16, 2024) |
| All-time low | $0.0712 (Nov 20, 2024) |
| 52-week high | $0.0932 |
| 52-week low | $0.0850 |
| Median price | $0.0897 |
| Average price | $0.0878 |
| Largest weekly change | +28.7% (Aug 21, 2024) |
| Weeks tracked | 102 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 37.5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 37.5 MG CAP, manufactured by Advagen Pharma Ltd., is $0.0850 per EA (NDC 72888017990), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL ER 37.5 MG CAP changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has risen 16.1%. It has been tracked across 102 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 37.5 MG CAP?
Since Jul 17, 2024, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has ranged from a low of $0.0712 (Nov 20, 2024) to a high of $0.0954 (Oct 16, 2024), with a median of $0.0897 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 37.5 MG CAP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as VENLAFAXINE HCL ER 37.5 MG CAP, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 37.5 MG CAP?
VENLAFAXINE HCL ER 37.5 MG CAP (NDC 72888017990) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification